News blog

Answer found for cancer drug failure

A recently approved cancer drug hailed as a miracle worker for some patients with advanced melanoma, has mysteriously failed in early clinical trials against colon cancers. But work published today in Nature clarifies how colon cancers dodge the drug, called vemurafenib, and what can be done to overcome this resistance. 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE